Overdose Prevention - FAME Session
- Non-Member - Free!
- Regular Member - Free!
- Retired - Free!
- Early Career Physician - Free!
- Resident - Free!
- Student - Free!
- Associate - Free!
- ASAM Staff - Free!
- International Member - Free!
- Emeritus Member - Free!
- Provisional Member - Free!
- Fellow Member - Free!
- Honorary Member - Free!
- CRT Member - Free!
This on-demand session will provide an overview of medications used in the treatment of OUD. It also covers the resources within the context of the COVID-19 pandemic and how it may impact the way that clinicians decide on medications for opioid use disorder.
This session was recorded as part of the ASAM Fundamentals of Addiction Medicine ECHO (FAME) sessions. The participation in the live FAME sessions will provide CME but viewing this on-demand recording will not provide CME. To attend upcoming live FAME sessions (eligible for CME) please sign up on the website: https://www.asam.org/education/live-online-cme/fundamentals-program/fame-teleecho.
By completing this session, you will be able to:
- Interact with patients and professional colleagues so as to display professionalism in all activities, by demonstrating commitment to the health and well-being of individuals and society through ethical practice, profession-led regulation, and high personal standards of behavior.
- Identify their feelings and attitudes that promote or prevent therapeutic responses to their patients with substance use disorders.
- Understand the addictive disorders as developmental biopsychosocial disorders.
- Take an evidence-based approach to detecting substance use disorders.
- Respond to positive substance use screening results with brief counseling strategies, appropriate to the patient’s readiness to change.
- Use motivational interviewing with patients ambivalent about changing their substance use behavior.
- Conduct a biopsychosocial and developmental ambulatory assessment of an adult with a suspected SUD to match the patient to an appropriate level of care.
- List the indications, contraindications and duration of treatment of evidence based pharmacotherapy for alcohol, tobacco, and opioid use disorders and refer patient to specialty care where appropriate.
- Reflect on the role of behavioral interventions for patients and families including formal intensive ambulatory and inpatient treatment and informal programs such as mutual aid groups in the recovery process for patients in their practice/ communities.
Original Recording Information
Date: Friday, May 1, 2020
Time: 11:00 am - 1:00 pm (ET)
Speaker:Alexander Y. Walley, MD, MSc
Alexander Y. Walley
MD, MSc, FASAM
Alexander Y. Walley, M.D., M.Sc., is an Associate Professor of Medicine at Boston University School of Medicine, a general internist and addiction medicine specialist at Boston Medical Center. He is the director of the Addiction Medicine Fellowship program and founded the Inpatient Addiction Consult Service at Boston Medical Center. He does clinical and research-related work on the medical complications of substance use, specifically HIV and overdose. He provides primary care and office-based buprenorphine treatment for HIV patients and methadone maintenance treatment. He is the medical director for the Massachusetts Department of Public Health’s Opioid Overdose Prevention Pilot Program.
No relevant financial disclosures.